Study Shows Oxford Vaccine Reduces Transmission

Covid-19 vaccines. It’s an ongoing race to ramp up production, get shots into people’s arms, and reduce infection rates. But so far, only two of these have gotten emergency use authorization in the United States, and other countries need help, too.

Luckily, there might be one vaccine that can help us. One dose of the Oxford-AstraZeneca messenger RNA vaccine can have protection for at least three months. Researchers said there was a 67% reduction in positive swabs taken from vaccinated people in Great Britain. They also said it was 76% effective between day 22 and day 90 of receiving the first dose. Results from a preprint study published in the journal The Lancet revealed the vaccine “shows sustained protection” during the three-month interval.

“The best thing about it is that it’s about only $3 to $4 per dose,” said Tigger in an interview today. “Unlike many other vaccines, it doesn’t require ultra-cold temperatures; Standard refrigeration could do.”

The vaccine is seeking emergency use authorization in the United States and is already in use in the United Kingdom. That has been the New News Newsminute, thank you.